Skip to Content

SHARE

Clinical Trials Details

Ozone

Observational, Receiving Zaltrap, Metastatic Colorectal Cancer

Objective

This observational study will describe the long term safety adn clinical outcomes of ZALTRAP in combination with FOLFORI in patients treated in daily practice for metastatic colorectal cancer after failure of oxaliplatin-based regimen.

Each patient will receive their treatment with ZALTRAP and FOLFORI as their physician prescribes but data will be collected from the first dose or until death.  No pre-defined visit schedule is planned and visits will take place at routine clinical practice.  Treatment related decisons will be made solely by the treating physician.

IRB Protocol Number
OBS13597
Principal Investigator(s)
Pamela Smith, MD
Sponsor(s)
Sanofi Group
Contact
Tauna Jeffery, RN at 406-435-7484
or tjeffery@billingsclinic.org

Location

  • Billings Clinic Hospital Fountain Courtyard - South of the Hospital Cafeteria
    2750 9th Ave North
    Billings, MT 59101